HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T A Korolenko Selected Research

N- (N- (3- carboxyoxirane- 2- carbonyl)leucyl)isoamylamine

2/2005Effect of cysteine protease inhibitor Ep-475 on TNF-alpha-independent cyclophosphamide-induced apoptosis in mouse lymphosarcoma LS cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T A Korolenko Research Topics

Disease

29Neoplasms (Cancer)
08/2015 - 01/2000
11Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2013 - 01/2000
9Hyperlipidemias (Hyperlipidemia)
02/2018 - 07/2009
8Neoplasm Metastasis (Metastasis)
08/2015 - 08/2001
7Hepatocellular Carcinoma (Hepatoma)
06/2004 - 01/2000
6Atherosclerosis
09/2015 - 01/2008
6Adenocarcinoma of Lung
08/2015 - 01/2000
4Lewis Lung Carcinoma
10/2012 - 08/2001
4Inflammation (Inflammations)
01/2012 - 04/2003
3Coronary Disease (Coronary Heart Disease)
06/2017 - 06/2009
3Adenocarcinoma
11/2008 - 04/2002
3Intrahepatic Cholestasis
10/2008 - 03/2007
2Dyslipidemias (Dyslipidemia)
11/2015 - 09/2015
2Experimental Leukemia
09/2009 - 09/2006
2Leukemia
09/2009 - 09/2006
2Gaucher Disease (Gaucher's Disease)
01/2009 - 10/2000
2Cholestasis
10/2008 - 01/2007
2Lymphoma (Lymphomas)
03/2008 - 01/2000
2Hepatitis C
12/2007 - 01/2007
2Hepatitis
03/2007 - 01/2003
2Opioid-Related Disorders (Opiate Addiction)
01/2007 - 04/2001
1Hypertension (High Blood Pressure)
02/2019
1Glucose Intolerance
02/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2019
1Heart Diseases (Heart Disease)
06/2017
1Hypercholesterolemia
06/2017
1Cardiovascular Diseases (Cardiovascular Disease)
06/2017
1Atherosclerotic Plaque (Atheroma)
09/2014
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2012
1Osteoporosis
03/2010
1Bone Resorption
03/2010
1Sarcoma (Soft Tissue Sarcoma)
01/2009
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
01/2009

Drug/Important Bio-Agent (IBA)

14Cystatin CIBA
02/2017 - 01/2000
14Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2013 - 01/2000
9chitotriosidaseIBA
11/2016 - 01/2000
8Triglycerides (Triacylglycerol)IBA
02/2019 - 07/2009
8Cathepsin BIBA
09/2009 - 01/2000
7Polysaccharides (Glycans)IBA
06/2017 - 11/2003
7Cysteine Proteases (Cysteine Protease)IBA
02/2017 - 07/2001
7EnzymesIBA
09/2014 - 10/2000
7CathepsinsIBA
11/2013 - 01/2003
6CholesterolIBA
02/2018 - 07/2009
6Poloxamer (Poloxamer 407)IBA
11/2016 - 06/2013
6LipidsIBA
03/2016 - 01/2009
6gadolinium chlorideIBA
09/2015 - 06/2004
6Matrix Metalloproteinases (MMPs)IBA
08/2015 - 07/2009
6Metalloproteases (Metalloproteinases)IBA
01/2012 - 03/2007
5Pharmaceutical PreparationsIBA
11/2013 - 01/2000
5tyloxapolFDA Link
06/2013 - 03/2007
4Therapeutic UsesIBA
02/2019 - 08/2001
4C-Reactive ProteinIBA
01/2012 - 04/2001
4Cathepsin DIBA
09/2009 - 01/2000
4Cysteine Proteinase InhibitorsIBA
02/2005 - 01/2000
4Antineoplastic Agents (Antineoplastics)IBA
03/2004 - 01/2000
4ukrainIBA
01/2000 - 01/2000
3LDL CholesterolIBA
02/2018 - 11/2016
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2017 - 06/2009
3Indicators and Reagents (Reagents)IBA
09/2015 - 07/2003
3Lipoproteins (Lipoprotein)IBA
09/2014 - 03/2004
3Peptide Hydrolases (Proteases)FDA Link
09/2009 - 07/2003
3polyglucosanIBA
01/2008 - 08/2001
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2008 - 01/2000
3Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2007 - 04/2001
3Cathepsin LIBA
12/2006 - 01/2000
2MannansIBA
02/2018 - 11/2016
2oxidized low density lipoproteinIBA
03/2016 - 03/2004
2DNA (Deoxyribonucleic Acid)IBA
11/2013 - 01/2000
2Cysteine (L-Cysteine)FDA Link
09/2009 - 11/2003
2Atorvastatin (Lipitor)FDA Link
09/2009 - 07/2009
2AlbuminsIBA
01/2007 - 04/2001
2Immunologic Factors (Immunomodulators)IBA
12/2006 - 09/2006
2Aspartic Acid ProteasesIBA
11/2003 - 01/2000
1Calcitonin Gene-Related PeptideIBA
02/2019
1FructoseIBA
02/2019
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2019
1SolutionsIBA
02/2019
1LDL Lipoproteins (beta Lipoproteins)IBA
06/2017
1AntibodiesIBA
12/2016
1Mannose ReceptorIBA
12/2016
1Lipase (Acid Lipase)FDA Link
11/2016
1Biomarkers (Surrogate Marker)IBA
09/2015
1GlucansIBA
09/2015
1Enzyme Precursors (Zymogens)IBA
08/2015
1Tissue Inhibitor of Metalloproteinase-2IBA
10/2012
1Tissue Inhibitor of Metalloproteinase-1IBA
10/2012
1Detergents (Detergent)IBA
10/2010
1Cathepsin KIBA
03/2010
1Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
01/2009
11-Naphthylisothiocyanate (1 Naphthylisothiocyanate)IBA
10/2008
1Glycoside Hydrolases (Endoglycosidases)IBA
05/2008
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
05/2008

Therapy/Procedure

12Therapeutics
01/2009 - 01/2000
3Drug Therapy (Chemotherapy)
09/2009 - 08/2001
3Transplantation
11/2008 - 06/2004
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2012 - 06/2009
2Intraperitoneal Injections
11/2008 - 10/2008
2Aftercare (After-Treatment)
05/2008 - 11/2003
1Transcutaneous Electric Nerve Stimulation (TENS)
02/2019
1Injections
06/2013